Humer Kristian has filed 7 insider transactions across 3 companies since July 2023.
Most recent transaction: a grant/award of 480000 shares of 4D Molecular Therapeutics, Inc. ($FDMT) on December 09, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | 4D Molecular Therapeutics, Inc. | $FDMT | Humer Kristian | Chief Financial Officer | A | Stock Option (Right to Buy) | 480000 | $0.00 | 480,000.0000 | 57,135,075 | 9999.99% | 0.84% |
| May 21, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | Humer Kristian | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 25,117,238 | 9999.99% | 0.08% |
| Jan. 22, 2025 | Foghorn Therapeutics Inc. | $FHTX | Humer Kristian | Chief Financial Officer | A | Stock Option (right to buy) | 120000 | $4.37 | 120,000.0000 | 54,899,432 | 9999.99% | 0.22% |
| June 11, 2024 | Sensei Biotherapeutics, Inc. | $SNSE | Humer Kristian | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 27,952,857 | 9999.99% | 0.07% |
| April 16, 2024 | Foghorn Therapeutics Inc. | $FHTX | Humer Kristian | Chief Financial Officer | A | Stock Option (Right to buy) | 275000 | $6.03 | 275,000.0000 | 41,974,484 | 9999.99% | 0.66% |
| July 10, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Humer Kristian | Director | A | Stock Option (Right to Buy) | 14550 | $0.00 | 14,550.0000 | 0 | 9999.99% | 0.00% |
| July 10, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Humer Kristian | Director | A | Common Stock | 4466 | $0.00 | 8,932.0000 | 0 | 100.00% | 0.00% |